Journal of Clinical Endocrinology & Metabolism, Vol 69, 1225-1233, Copyright © 1989 by Endocrine Society

ARTICLES

Increased growth hormone pulse frequency in acromegaly

AL Barkan, SE Stred, K Reno, M Markovs, NJ Hopwood, RP Kelch and IZ Beitins
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109.

To investigate whether GH secretion in acromegaly is subject to regulatory control by the hypothalamic GH-releasing hormone (GHRH) we studied GH secretion in 22 patients with acromegaly. Parameters of pulsatile GH secretion were assessed using frequent blood sampling (every 20 or 10 min for 24 h). Acute GH responses to GHRH-44 (0.1, 0.33, and 1.0 micrograms/kg BW, iv) were measured, and GH secretion during therapy with the long-acting somatostatin analog SMS 201-995 (Sandoz) was assessed. The results were compared to those in normal volunteers. Spontaneous GH pulse frequency was greater in patients with acromegaly than in 6 control subjects (8.6 +/- 0.6 vs. 4.3 +/- 1.1 pulses/24 h), as estimated by the 20-min sampling frequency. The 10-min sampling frequency revealed 12.9 +/- 0.7 pulses/24 h in acromegalics. Spontaneous GH pulse amplitude and acute GH rises in response to GHRH did not differ between control and acromegalic subjects. A similar degree of nocturnal augmentation of GH secretion was observed in both groups, and it persisted during SMS 201-995 therapy in patients with acromegaly. These observations suggest that GH secretion in acromegaly remains under stimulatory control by GHRH, which may be released at an abnormally high rate.

This article has been cited by other articles:

				A A van der Klaauw, A M Pereira, S W van Thiel, J W A Smit, E P M Corssmit, N R Biermasz, M Frolich, A Iranmanesh, J D Veldhuis, F Roelfsema, et al. GH deficiency in patients irradiated for acromegaly: significance of GH stimulatory tests in relation to the 24 h GH secretion. Eur. J. Endocrinol., June 1, 2006; 154(6): 851 - 858. [Abstract] [Full Text] [PDF]

				C. A. Jaffe, W. Pan, M. B. Brown, R. DeMott-Friberg, and A. L. Barkan Regulation of GH Secretion in Acromegaly: Reproducibility of Daily GH Profiles and Attenuated Negative Feedback by IGF-I J. Clin. Endocrinol. Metab., September 1, 2001; 86(9): 4364 - 4370. [Abstract] [Full Text] [PDF]

				S. R. Peacey, A. A. Toogood, J. D. Veldhuis, M. O. Thorner, and S. M. Shalet The Relationship between 24-Hour Growth Hormone Secretion and Insulin-Like Growth Factor I in Patients with Successfully Treated Acromegaly: Impact of Surgery or Radiotherapy J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 259 - 266. [Abstract] [Full Text]

				R. G. Veldman, M. Frölich, S. M. Pincus, J. D. Veldhuis, and F. Roelfsema Apparently Complete Restoration of Normal Daily Adrenocorticotropin, Cortisol, Growth Hormone, and Prolactin Secretory Dynamics in Adults with Cushing's Disease after Clinically Successful Transsphenoidal Adenomectomy J. Clin. Endocrinol. Metab., November 1, 2000; 85(11): 4039 - 4046. [Abstract] [Full Text]

				R. Lanzi, M. Losa, G. Mignogna, A. Caumo, and A. E. Pontiroli The Control on Growth Hormone Release by Free Fatty Acids Is Maintained in Acromegaly J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1234 - 1238. [Abstract] [Full Text]

				S. R. Peacey, A. A. Toogood, and S. M. Shalet Hypothalamic Dysfunction in "Cured" Acromegaly Is Treatment Modality Dependent J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1682 - 1686. [Abstract] [Full Text]